Human P-glycoprotein is active when the two halves are clamped together in the closed conformation.

[1]  Michael M. Gottesman,et al.  Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells , 1986, Cell.

[2]  M. Melamed,et al.  Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[3]  D. Clarke,et al.  Rapid Purification of Human P-glycoprotein Mutants Expressed Transiently in HEK 293 Cells by Nickel-Chelate Chromatography and Characterization of their Drug-stimulated ATPase Activities (*) , 1995, The Journal of Biological Chemistry.

[4]  D. Clarke,et al.  P-glycoprotein , 1995, The Journal of Biological Chemistry.

[5]  D. Clarke,et al.  Membrane Topology of a Cysteine-less Mutant of Human P-glycoprotein (*) , 1995, The Journal of Biological Chemistry.

[6]  D. Gadsby,et al.  ATP hydrolysis cycles and mechanism in P-glycoprotein and CFTR. , 1997, Seminars in cancer biology.

[7]  D. Clarke,et al.  Identification of Residues in the Drug-binding Site of Human P-glycoprotein Using a Thiol-reactive Substrate* , 1997, The Journal of Biological Chemistry.

[8]  S. Ambudkar,et al.  Relation Between the Turnover Number for Vinblastine Transport and for Vinblastine-stimulated ATP Hydrolysis by Human P-glycoprotein* , 1997, The Journal of Biological Chemistry.

[9]  I. Pastan,et al.  Biochemical, cellular, and pharmacological aspects of the multidrug transporter. , 1999, Annual review of pharmacology and toxicology.

[10]  D. Clarke,et al.  The human multidrug resistance P‐glycoprotein is inactive when its maturation is inhibited: potential for a role in cancer chemotherapy , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  D. Clarke,et al.  Defining the Drug-binding Site in the Human Multidrug Resistance P-glycoprotein Using a Methanethiosulfonate Analog of Verapamil, MTS-verapamil* , 2001, The Journal of Biological Chemistry.

[12]  F. Sharom,et al.  FRET analysis indicates that the two ATPase active sites of the P-glycoprotein multidrug transporter are closely associated. , 2001, Biochemistry.

[13]  A. E. Senior,et al.  Projection Structure of P-glycoprotein by Electron Microscopy , 2002, The Journal of Biological Chemistry.

[14]  D. Clarke,et al.  The “LSGGQ” Motif in Each Nucleotide-binding Domain of Human P-glycoprotein Is Adjacent to the Opposing Walker A Sequence* , 2002, The Journal of Biological Chemistry.

[15]  D. Clarke,et al.  Location of the Rhodamine-binding Site in the Human Multidrug Resistance P-glycoprotein* , 2002, The Journal of Biological Chemistry.

[16]  D. Clarke,et al.  Methanethiosulfonate Derivatives of Rhodamine and Verapamil Activate Human P-glycoprotein at Different Sites* , 2003, Journal of Biological Chemistry.

[17]  D. Clarke,et al.  Permanent Activation of the Human P-glycoprotein by Covalent Modification of a Residue in the Drug-binding Site* , 2003, Journal of Biological Chemistry.

[18]  D. Clarke,et al.  Val133 and Cys137 in Transmembrane Segment 2 Are Close to Arg935 and Gly939 in Transmembrane Segment 11 of Human P-glycoprotein* , 2004, Journal of Biological Chemistry.

[19]  D. Clarke,et al.  Disulfide Cross-linking Analysis Shows That Transmembrane Segments 5 and 8 of Human P-glycoprotein Are Close Together on the Cytoplasmic Side of the Membrane* , 2004, Journal of Biological Chemistry.

[20]  R. Dawson,et al.  Structure of a bacterial multidrug ABC transporter , 2006, Nature.

[21]  D. Clarke,et al.  Transmembrane segment 1 of human P-glycoprotein contributes to the drug-binding pocket. , 2006, The Biochemical journal.

[22]  K. Linton,et al.  Evidence for a Sav1866‐like architecture for the human multidrug transporter P‐glycoprotein , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  K. Locher,et al.  Structure of the multidrug ABC transporter Sav1866 from Staphylococcus aureus in complex with AMP‐PNP , 2007, FEBS letters.

[24]  Stephan Kopp,et al.  Catalytic cycle of ATP hydrolysis by P-glycoprotein: evidence for formation of the E.S reaction intermediate with ATP-gamma-S, a nonhydrolyzable analogue of ATP. , 2007, Biochemistry.

[25]  Jean-Paul Becker,et al.  Molecular models of human P-glycoprotein in two different catalytic states , 2009, BMC Structural Biology.

[26]  D. Clarke,et al.  Arginines in the First Transmembrane Segment Promote Maturation of a P-glycoprotein Processing Mutant by Hydrogen Bond Interactions with Tyrosines in Transmembrane Segment 11* , 2008, Journal of Biological Chemistry.

[27]  D. Clarke,et al.  Processing Mutations Disrupt Interactions between the Nucleotide Binding and Transmembrane Domains of P-glycoprotein and the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)* , 2008, Journal of Biological Chemistry.

[28]  Michael Wiese,et al.  Identification of Putative Binding Sites of P‐glycoprotein Based on its Homology Model , 2008, ChemMedChem.

[29]  Thomas J. Raub,et al.  Rhodamine inhibitors of P-glycoprotein: an amide/thioamide "switch" for ATPase activity. , 2009, Journal of medicinal chemistry.

[30]  D. Clarke,et al.  Identification of Residues in the Drug Translocation Pathway of the Human Multidrug Resistance P-glycoprotein by Arginine Mutagenesis* , 2009, The Journal of Biological Chemistry.

[31]  Alexandre M J J Bonvin,et al.  Data‐driven homology modelling of P‐glycoprotein in the ATP‐bound state indicates flexibility of the transmembrane domains , 2009, The FEBS journal.

[32]  Michael M Gottesman,et al.  Structure of a multidrug transporter , 2009, Nature Biotechnology.

[33]  Stephen G. Aller.  Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding , 2010 .